Key facts
- This page summarizes Steven R. Loranger's Form 4 filing for Edwards Lifesciences Corp (EW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 14 Feb 2025, 16:41.
Steven R. Loranger - 14 Feb 2025 Form 4 Insider Report for Edwards Lifesciences Corp (EW)
- Reporting relationship
- Director
- Issuer ticker
- EW
- Reported as of
- 14 Feb 2025
- Net transaction value
- -$178,503
- SEC form
- 4
- Accepted by SEC
- 14 Feb 2025, 16:41:55 UTC
- Prior SEC filing
- 17 May 2024
- Next SEC filing
- 09 May 2025
- Source filing
- View source filing
- Reporting owner signature
- Linda J. Park, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steven R. Loranger filed Form 4 for Edwards Lifesciences Corp (EW) on 14 Feb 2025.
Change
- Previous filing in this sequence was filed on 17 May 2024.
- Current net transaction value: -$178,503.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EW
transaction
Common Stock
Options Exercise
- Transaction value
- $260,073
- Shares
- +5,739
- Change %
- +9.5%
- Price
- $45.32
- Shares after
- 66,111
- Date
- 14 Feb 2025
- Ownership
- Direct
EW
transaction
Common Stock
Sale
- Transaction value
- $438,576
- Shares
- -5,739
- Change %
- -8.7%
- Price
- $76.42
- Shares after
- 60,372
- Date
- 14 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
EW
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,000
- Date
- 14 Feb 2025
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EW
transaction
Derivative
Director Stock Option (Right to Acquire)
Options Exercise
- Transaction value
- $0
- Shares
- -5,739
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 14 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,739
- Exercise price
- $45.32
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This transaction was executed in multiple trades at prices ranging from $76.400 to $76.435. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
SEC remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.